Company IR-Med Inc.

Equities

IRME

US46265R1032

Medical Equipment, Supplies & Distribution

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 09:30:00 2024-05-20 EDT			5-day change	1st Jan Change
0.585 ^USD	-4.68%		-35.00%	-49.13%

04-05	IR-Med Inc.'S PressureSafe Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries	CI
04-01	IR-Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

IR-Med, Inc. is a development-stage medical device company. The Company is engaged in developing its technology through its subsidiary and is utilizing Infra-Red-light spectroscopy (IR) combined with artificial intelligence (AI) technology platform to develop non-invasive devices for various medical indications, by detecting and measuring various biomarkers and molecules in the blood and in human tissue in real-time. The Company has three principal medical devices in development. Its product under development, PressureSafe, is a handheld optical monitoring device that is being developed to support early detection of pressure injuries (PI) to the skin and underlying tissue. DiaSafe is a handheld optical monitoring device that is being developed to support early detection of DFUs in lower limb skin and underlying tissue. Nobiotics is an otoscope designed to support physicians with an immediate indication as to whether a mid-ear infection (otitis media) is of a bacterial origin.

Number of employees: 8

Managers	Title	Age	Since
Aharon Klein CEO	Chief Executive Officer	60	-
Oded Bashan FOU	Founder	77	-
Sharon Levkoviz DFI	Director of Finance/CFO	50	-
Avi Vachnis PRN	Corporate Officer/Principal	-	-
Aharon Binur PRN	Corporate Officer/Principal	60	21-04-28

Members of the board	Title	Age	Since
Oded Bashan FOU	Founder	77	-
Ohad Bashan BRD	Director/Board Member	53	-
Ron Abraham Mayron BRD	Director/Board Member	59	21-02-28
Aharon Klein CEO	Chief Executive Officer	60	-
Yaniv Cohen FOU	Founder	44	07-03-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	69,975,056	22,043,445 ( 31.50 %)	0	31.50 %

Name	Equities	%	Valuation
Oded Bashan 12.31 %	8,609,916	12.31 %	9 M $
Yaniv Cohen 11.24 %	7,859,136	11.24 %	8 M $
Aharon Klein 11.24 %	7,859,110	11.24 %	8 M $
Isamar Margareten 6.689 %	4,677,841	6.689 %	5 M $
Yaakov Safren 5.934 %	4,150,001	5.934 %	4 M $
Yoram Drucker 5.791 %	4,050,000	5.791 %	4 M $
David Levy 5.506 %	3,850,607	5.506 %	4 M $
Paul Coulson 5.362 %	3,750,000	5.362 %	4 M $
Third Eye Investments LLC 4.469 %	3,125,000	4.469 %	3 M $
Ohad Bashan 0.000000 %	0	0.000000 %	- $

IR-Med, Inc.

Z.H.R Industrial Zone 20 Yahalom St

1210002, Rosh Pinna

http://www.ir-medical.com

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
IR-MED INC.	-49.13%	42.95M
ABBOTT LABORATORIES	-6.23%	181B
MEDTRONIC PLC	+2.59%	114B
BECTON, DICKINSON AND COMPANY	-2.75%	68.29B
DEXCOM, INC.	+5.32%	52.24B
CENCORA, INC.	+7.61%	44.3B
HOYA CORPORATION	+5.19%	42.73B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.17%	32.52B
TERUMO CORPORATION	+17.50%	26.02B
WEST PHARMACEUTICAL SERVICES, INC.	-2.66%	25.91B

Other Medical Equipment, Supplies & Distribution